Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
C4 Therapeutics (CCCC) has provided an update.
The Company has announced Mr. Cooper’s addition to its Board with a press release, emphasizing that while this information is publicly shared, it isn’t considered formally filed or subject to certain legal liabilities. The release also clarifies that the announcement doesn’t imply the information’s materiality for investment decisions.
Learn more about CCCC stock on TipRanks’ Stock Analysis page.